Incomplete Deletion of IL-4Rα by LysM Reveals Distinct Subsets of M2 Macrophages Controlling Inflammation and Fibrosis in Chronic Schistosomiasis
Chronic injury and inflammation lead to irreversible fibrosis in a range of diseases and infections. Macrophages alternatively activated by the immune system are capable of regulating inflammation and fibrosis, but our understanding of the source and function of these cells is incomplete. Mice genetically engineered to specifically prevent macrophages from becoming alternatively activated have been used to study the cells' role following infection with the parasite, Schistosoma mansoni. To our surprise, we found these mice prevent alternative activation only in macrophages that have had time to mature and some, perhaps more nascent, macrophages can become alternatively activated following exposure to S. mansoni eggs. We detected lower expression of Lyz2 gene in these cells, leading to less expression of the enzyme excising the receptor gene necessary for alternative activation. Following S. mansoni infection, the livers of these mice have similar levels of fibrosis but significantly more inflammation compared to controls. We conclude that during schistosomiasis, distinct populations of alternatively activated macrophages control inflammation and fibrosis: macrophages expressing low levels of Lyz2 express Arg1 and thus are sufficient to control fibrosis, while more mature Lyz2-expressing macrophages are required for downmodulation of egg-induced inflammation in chronic schistosomiasis.
Published in the journal:
. PLoS Pathog 10(9): e32767. doi:10.1371/journal.ppat.1004372
Category:
Research Article
doi:
https://doi.org/10.1371/journal.ppat.1004372
Summary
Chronic injury and inflammation lead to irreversible fibrosis in a range of diseases and infections. Macrophages alternatively activated by the immune system are capable of regulating inflammation and fibrosis, but our understanding of the source and function of these cells is incomplete. Mice genetically engineered to specifically prevent macrophages from becoming alternatively activated have been used to study the cells' role following infection with the parasite, Schistosoma mansoni. To our surprise, we found these mice prevent alternative activation only in macrophages that have had time to mature and some, perhaps more nascent, macrophages can become alternatively activated following exposure to S. mansoni eggs. We detected lower expression of Lyz2 gene in these cells, leading to less expression of the enzyme excising the receptor gene necessary for alternative activation. Following S. mansoni infection, the livers of these mice have similar levels of fibrosis but significantly more inflammation compared to controls. We conclude that during schistosomiasis, distinct populations of alternatively activated macrophages control inflammation and fibrosis: macrophages expressing low levels of Lyz2 express Arg1 and thus are sufficient to control fibrosis, while more mature Lyz2-expressing macrophages are required for downmodulation of egg-induced inflammation in chronic schistosomiasis.
Introduction
Tissue macrophages exhibit substantial plasticity and can quickly change their function in response to different stimuli found in the local milieu [1], and distinct subsets with characteristic functional activities have been described. Alternatively activated macrophages (AAMs), also called M2 or M(IL-4) [2], are induced in response to the type-2 cytokines IL-4 and IL-13 [3], exhibit potent immunoregulatory activity, and have been linked with mechanisms controlling wound healing and fibrosis [4]. In addition to expressing mediators that directly regulate wound repair pathways such as arginase 1 (Arg1), resistin-like molecule alpha (Relm-α), transforming growth factor beta-1 (TGF-β1), vascular endothelial growth factor (VEGF), and insulin-like growth factor-1 (IGF-1) [5], AAMs also suppress pro-inflammatory Th1, Th17, and classically activated macrophage (CAMs) responses that contribute to tissue injury [6].
To prevent alternative activation, Herbert and colleagues generated macrophage/neutrophil-specific IL-4Rα-deficient mice (IL-4Rαflox/ΔLysMCre) by expressing Cre recombinase in the regulatory region of the lysozyme M gene expressed in macrophages and neutrophils. They showed AAMs are required to suppress pathogenic Th1/CAM responses during infection with the helminth parasite Schistosoma mansoni [7]. However, AAMs had no significant impact on the development of the Th2 response or fibrosis.
In contrast to IL-4Rαflox/ΔLysMCre mice, mice with a macrophage/neutrophil-specific deletion of Arg1 (Arg1flox/ΔLysMCre), an enzyme involved in the conversion of L-arginine into L-ornithine and urea, developed enhanced type-2 effector responses following S. mansoni infection without acute type-1 cytokine-driven hepatotoxicity or endotoxemia [8]. Pesce et al. observed Arg1flox/ΔLysMCre mice developed stronger CD4+ Th2 cell responses, larger eosinophil-rich granulomas, more severe liver fibrosis, and failed to down-regulate the type-2 inflammatory response when chronically infected, suggesting that Arg1+ macrophages critically suppress granulomatous inflammation, fibrosis, and mortality [9]. Similar but even more dramatic findings were observed with Arg1flox/floxTie2Cre mice, which delete Arg1 in all macrophage populations [8].
The ability of IL-4Rαflox/ΔLysMCre mice to control fibrosis during S. mansoni infection was completely unexpected, since Arg1 expression in macrophages was thought to be highly dependent on IL-4Rα signaling [7]. Because it was concluded that IL-4Rα-expressing AAMs suppress lethal type-1-associated inflammation during acute schistosomiasis, while arginase 1-expressing AAMs are dispensable during the acute stage, we theorized that an IL-4Rα-dependent but arginase 1-independent mechanism was responsible for the early protective activity exhibited by AAMs. To identify this mechanism, we set out to compare pathology, fibrosis, and the macrophage phenotype of IL-4Rαflox/ΔLysMCre mice and Arg1flox/ΔLysMCre mice following S. mansoni infection. We began by systematically studying IL-4Rαflox/ΔLysMCre mice during acute and chronic infection, and unexpectedly, we identified a subset of IL-4Rα-expressing macrophages that are resistant to LysMCre-mediated gene deletion, exhibited an Arg1+ AAM phenotype, and regulated type-2 cytokine-dependent fibrosis. In contrast, we identified mature Lyz2hi tissue macrophages that are susceptible to LysMCre-mediated gene deletion as the critical population of AAMs mediating the downmodulation of granuloma formation in chronic schistosomiasis. So while these data suggest that the LysMCre deleter mouse is only useful for studying gene function in mature tissue macrophages, we were able to demonstrate that distinct populations of Lyz2hi and Lyz2lo AAMs collaborate to control inflammation and fibrosis in schistosomiasis, respectively. In chronic inflammatory diseases where the recruitment of immature monocytes/macrophages, differentiation to mature tissue macrophages, and acquisition of the alternatively activated phenotype is a dynamic and ongoing process, LysMCre can be used to distinguish the contribution of genes expressed in Lyz2hi and Lyz2lo macrophages.
Results
Surviving chronic S. mansoni infection depends on Il4rα allele, not LysMCre expression
The previous study by Herbert et al. found nearly 100% of IL-4Rαflox/ΔLysMCre mice succumbed to infection by 8 weeks post-infection [7]. Those experiments were conducted with 75–100 S. mansoni cercariae, a relatively high dose of parasites. To further elucidate the role of AAMs during a chronic S. mansoni infection and to explore the role of IL-4Rα-expressing macrophages in the initiation and regulation of fibrosis, we infected IL-4Rαflox/ΔLysMCre mice and IL-4Rαflox/Δ littermate control mice with 35 cercariae, a dose that in wild-type mice leads to substantial disease and liver fibrosis but low mortality through the chronic phase of infection [10]. We hypothesized that lighter infections would enable us to quantify fibrosis, characterize the immune response, and phenotype the macrophage response in the granulomatous liver at both acute (9 weeks post-infection) and chronic (16 weeks post-infection) time-points. We observed 30–40% of the infected littermate control group (IL-4Rαflox/Δ) died through week 16 of infection (Fig. 1A). Surprisingly, we observed equal mortality in the IL-4Rαflox/ΔLysMCre group, suggesting that AAMs might be less important to survival in schistosomiasis than previously thought. The majority of the deaths occurred during the acute phase of the infection when the host immune response peaks and before additional protective mechanisms like IL-10 or the IL-13 decoy receptor (IL-13Rα2) are fully activated [11]. After week 10 of infection, few deaths were observed in either group. In the prior study, IL-4Rαflox/ΔLysMCre mice infected with ≥75 cercariae developed hepatotoxicity and gut pathology leading to endotoxemia and death. The authors also observed a stronger type-1 immune response in the IL-4Rαflox/ΔLysMCre mice, defined by increased IFN-γ production, which they hypothesized was contributing to the rapid death of the mice. Intriguingly, in our studies with IL-4Rαflox/ΔLysMCre mice infected with fewer cercariae, we observed no increase in IFN-γ (Fig. 1B) or hepatotoxicity at either acute or chronic time points (Fig. 1C). Importantly, we included wild-type IL-4Rαflox/flox mice and IL-4RαΔ/Δ mice in the survival study to demonstrate universal deletion of IL-4Rα on one chromosome is the explanation for the enhanced mortality of both flox/Δ cohorts (Fig. 1A). As expected, mice with two copies deleted (Δ/Δ), showed the most susceptibility. We confirmed the infectious burdens were not different between the groups (Fig. S1). Because this finding was unexpected, we also tested a higher infectious dose. While an increase from 35 to 100 cercariae accelerated and significantly increased mortality in both groups, there was still no significant difference in mortality between the IL-4Rαflox/ΔLysMCre mice and IL-4Rαflox/Δ littermate controls (Fig. S2).
Inflammation but not fibrosis was exacerbated in chronically infected IL-4Rαflox/ΔLysMCre mice
Intestinal lesions and hepatotoxicity were reported as the pathological features of high dose schistosomiasis in IL-4Rαflox/ΔLysMCre mice [7]. Consequently, we examined the liver and intestine at weeks 9 and 16 post-infection to determine whether similar pathological changes were occurring following infection with 35 cercariae. Strikingly, even after 16 weeks of infection, an experienced pathologist failed to detect any increase in intestinal damage in the IL-4Rαflox/ΔLysMCre group when compared with littermate control mice (Fig. 2A), which likely explains the equivalent survival. Liver sections were stained with Giemsa to quantify the granulomatous inflammatory response (Fig. 2B) and with picrosirius red to evaluate the accumulation of liver collagen at acute and chronic time points (Fig. 2C). Granulomas appeared normally organized in IL-4Rαflox/ΔLysMCre mice with an equivalent proportion of eosinophils, but granuloma size increased significantly compared to littermate controls at both 9 and 16 weeks post-infection (Fig. 2B and 2D). Like Herbert et al., we found the exacerbated granulomatous inflammation led to only subtle increases in fibrosis, however, and did not lead to statistically significant increases in chronic fibrosis, determined qualitatively by picrosirius red staining (Fig. 2C) and quantitatively by hydroxyproline assay (Fig. 2E). These observations suggest that while AAMs limit granulomatous inflammation at both acute and chronic time points, additional regulatory mechanisms limit the progression of fibrosis. This interpretation was surprising because uncontrolled granulomatous inflammation in the liver has been hypothesized to contribute to the development of fibrosis in infected mice and humans [12], [13]. These data were also difficult to interpret because Arg1-expressing AAMs are critical to the suppression of fibrosis in infected mice [8], and their numbers should have been greatly diminished in the IL-4Rαflox/ΔLysMCre mice according to Herbert et al. and others who have demonstrated Arg1 expression in macrophages is highly dependent on IL-4Rα signaling [7], [14], [15].
In vivo evidence of alternative macrophage activation in IL-4Rαflox/ΔLysMCre mice
Recently, we showed that multiple mechanisms collaborate to slow the progression of fibrosis during chronic schistosome infection [10]. These included IL-13Rα2, a high-affinity decoy receptor for IL-13 [16], [17], IL-12p40, a key driver of Th1 and Th17 responses [18], and IL-10, a potent immunosuppressive cytokine [11], [19]. To determine whether the induction of any of these important immunoregulatory mechanisms was altered in the IL-4Rαflox/ΔLysMCre mice, we analyzed their expression in the granulomatous livers of acutely and chronically infected mice. Levels of IL-13Rα2 in the serum, whether circulating free or bound to IL-13, were indistinguishable between infected IL-4Rαflox/Δ control and IL-4Rαflox/ΔLysMCre mice (Fig. 3A). Likewise, IL-12p40 and IL-10 mRNA were expressed at similar levels in the livers of IL-4Rαflox/Δ littermate controls and IL-4Rαflox/ΔLysMCre mice at 9 and 16 weeks post-infection (Fig. 3B). Expression of both IL-4 and IL-13 by CD4+ T cells, the principal stimuli driving fibrosis in this system [20], [21], increased identically at 9 weeks post-infection and remained at equivalent levels through week 16 (Fig. 3C). Consistent with the leukocyte responses, we observed no significant increases in IL-4 or IL-13 gene expression in the livers (Fig. 4) or intestines (not shown) of IL-4Rαflox/ΔLysMCre mice when compared with expression in IL-4Rαflox/Δ littermate controls 9 and 16 weeks post-infection. These observations suggested a much less critical role for IL-4Rα-expressing AAMs during the chronic response to low dose S. mansoni infections.
Surprisingly, however, after further analysis of gene expression in the liver, we found the IL-4Rαflox/ΔLysMCre mice displayed no reduction in the expression of multiple genes that characterize the AAM phenotype [22], including Chi3l3 (encoding Ym1), Retnla (Relm-α), and Arg1 (Fig. 4). Together, the similarities in pathology, survival, and gene expression indicated that in our experiments with IL-4Rαflox/ΔLysMCre mice, AAM development was not substantially impaired or at least not to the degree previously suggested [7], [23].
A population of IL-4Rα-expressing myeloid cells resisted LysMCre-mediated deletion
We hypothesized that a subset of myeloid cells in IL-4Rαflox/ΔLysMCre mice resisted LysMCre-mediated gene deletion, remained IL-4Rα-positive, and developed into AAM-like cells with immunoregulatory activity. To test for functional expression of IL-4Rα in different leukocyte populations, we isolated peritoneal cells from naïve controls and IL-4Rαflox/ΔLysMCre mice, stimulated them with IL-4, and measured STAT6 phosphorylation. We used flow cytometry to analyze peritoneal lymphocytes and macrophages separately (Fig. 5A). Lymphocytes (Fig. 5B) and macrophages (Fig. 5C) harvested from wild-type BALB/c and naïve IL-4Rαflox/Δ littermate controls phosphorylated STAT6 to the same degree. Lymphocytes from IL-4Rαflox/ΔLysMCre mice also exhibited normal STAT6 phosphorylation in response to IL-4 (Fig. 5B). In contrast, macrophages from naïve LysMCre-expressing mice displayed no STAT6 phosphorylation (Fig. 5C), confirming the ablation of IL-4Rα signaling in resident peritoneal macrophages.
Inflammatory immune responses recruit, expand, and replace diverse populations of myeloid cells, and while there is strong evidence that resident tissue macrophages can also expand by proliferating [24], [25], resident cells may become rapidly and greatly outnumbered by monocyte-derived differentiating cells [26]. Therefore, we next examined whether IL-4Rαflox/ΔLysMCre macrophages elicited in response to a sterile inflammatory stimulus are as defective as the resident tissue macrophage population in their response to IL-4. We injected IL-4Rαflox/ΔLysMCre and littermate control mice intraperitoneally (i.p.) with thioglycollate (a stimulus recently shown to elicit only bone-marrow derived inflammatory cells and not to expand tissue resident cells [27]), harvested peritoneal cells 4 days later, and repeated our IL-4-induced phospho-STAT6 assay (Fig. 5D). Lymphocytes again displayed similar STAT6 phosphorylation in response to IL-4 (Fig. 5E). But critically, over a quarter of the thioglycollate-elicited F4/80hiCD11bhi macrophages from IL-4Rαflox/ΔLysMCre mice were still able to respond to IL-4 as shown by phosphorylated STAT6 (Fig. 5F). Quantification and statistics are shown in Fig. S3. To confirm that this phenomenon is a reflection of genomic rearrangement of the Il4rα locus, we isolated DNA from F4/80hiCD11bhi macrophages FACS sorted from naïve and thioglycollate-treated IL-4Rαflox/ΔLysMCre mice alongside IL-4Rαflox/flox, IL-4Rαflox/Δ, and IL-4RαΔ/Δ controls. As expected, in macrophages sorted from naïve IL-4Rαflox/ΔLysMCre mice, the wild-type (WT) Il4rα allele was present minimally compared to the knockout (KO) allele (Fig. 5G). In contrast, the WT Il4rα allele was markedly more abundant in macrophages taken from thioglycollate-treated IL-4Rαflox/ΔLysMCre mice. Together, these data consistently demonstrate that amongst inflammatory cells in IL-4Rαflox/ΔLysMCre mice, a subset of F4/80hiCD11bhi macrophages fails to delete the floxed Il4rα gene as expected and therefore remains capable of undergoing IL-4Rα-mediated alternative activation.
We hypothesized that the discrepancy in Il4rα excision is explained by differential expression of Lyz2 (encoding lysozyme M) by the naïve and thioglycollate-elicited peritoneal macrophage populations. We sorted CD11bhiF4/80hi macrophages from both peritoneal environments and measured Lyz2 expression. The magnitude of Lyz2 expression is lower in IL-4Rαflox/ΔLysMCre mice than corresponding Cre-negative controls because IL-4Rαflox/ΔLysMCre mice transcribe Cre rather than lysozyme M at one locus [28], but in support of the hypothesis, naive macrophages expressed significantly more Lyz2 than thioglycollate-elicited macrophages in both IL-4Rαflox/Δ and IL-4Rαflox/ΔLysMCre mice (Fig. 5H).
Lyz2lo macrophages developed features of AAMs in response to S. mansoni eggs
We next examined whether type-2 response-inducing schistosome eggs also generate a subset of inflammatory macrophages that resists LysMCre-mediated gene deletion. For these studies, we directly compared four distinct populations of peritoneal macrophages: resident macrophages (naïve), S. mansoni egg-elicited macrophages 4 days following i.p. egg injection (1o), S. mansoni egg-elicited macrophages 18 days following i.p. egg injection (1o-rested), and macrophages from mice injected i.p. with eggs twice over 14 days and then harvested 4 days after the second challenge (1o-rechallenged). F4/80hiCD11bhi peritoneal macrophages were sorted from each group (representative flow plots and cytospins in Fig. 6A–B; images for each condition are shown in Fig. S4), and Il4rα and Lyz2 mRNA expression was quantified by qPCR. Resident peritoneal macrophages isolated from naïve IL-4Rαflox/ΔLysMCre mice had indeed ablated Il4rα expression (Fig. 6C). In the resident population, IL-4Rα mRNA expression decreased to less than 15% of littermate levels, explaining the absence of IL-4-induced STAT6 phosphorylation, and concurring with the initially reported efficiency of LysMCre-mediated excision [28]. Strikingly, the peritoneal macrophages isolated from IL-4Rαflox/ΔLysMCre mice 4 days after egg challenge (1o) expressed Il4rα at a level near 50% of littermates. If the macrophages were isolated on day 18 rather than on day 4 after egg challenge (1o-rested), more than 50% of the F4/80hiCD11bhi macrophages had deleted Il4rα, suggesting that maturation in residence or proliferation of resident cells are factors influencing Cre-mediated excision of Il4rα. In marked contrast, IL-4Rαflox/ΔLysMCre peritoneal macrophages purified 4 days after the second dose of S. mansoni eggs (1o-rechallenged) showed no reduction in Il4rα expression compared with littermate controls (Fig. 6C), suggesting that recently recruited and differentiated F4/80hiCD11bhi macrophages had yet to undergo LysMCre-mediated excision. Compared side-by-side, these data suggest that new F4/80hiCD11bhi macrophages (through recruitment or proliferation) were most resistant to LysMCre-mediated gene deletion.
As observed with naïve and thioglycollate-elicited macrophages, we hypothesized that differences in expression of Lyz2 in resident, rested, and recently recruited macrophages explain the pattern of IL-4Rα expression observed in macrophages isolated from the Cre-expressing mice. As expected, resident naive peritoneal macrophages expressed the most Lyz2 (Fig. 6C, right panel). In littermate IL-4Rαflox/Δ mice, Lyz2 expression by macrophages was between 50–75% as high in the 1o and the 1o-rested populations and less than 25% as high in the 1o-rechallenged cells (Fig. 6C, right panel). The greater than 75% reduction in Lyz2 expression observed in the 1o-rechallenged F4/80hiCD11bhi macrophages likely explains why the greatest fraction of these cells are resistant to LysMCre-mediated deletion and remain IL-4Rα positive.
Finally, to confirm that inflammatory macrophages in the IL-4Rαflox/ΔLysMCre mice are capable of becoming alternatively activated in response to schistosome eggs in vivo, we isolated F4/80hiCD11bhi macrophages from the naïve, 1o-rested, 1o-rechallenged groups and analyzed the gene expression of several well-documented markers of alternative macrophage activation including Mrc1 (mouse mannose receptor, C type 1), Chi3l3, Retnla, and Arg1. As expected, there was no evidence of alternative activation in the macrophages isolated from naive mice unexposed to schistosome eggs (Fig. 6D and 6E). However, consistent with Il4rα expression (Fig. 6C), F4/80hiCD11bhi macrophages isolated from littermate control and IL-4Rαflox/ΔLysMCre 1o-rechallenged groups displayed marked and equivalent increases in Mrc1, Chi3l3, Retnla, and Arg1 mRNA expression (Fig. 6D). They also displayed similar cell surface expression of the mannose receptor (Fig. 6E) and nearly identical arginase activity (Fig. 6F). In contrast, if the egg-elicited macrophages were left two weeks to rest in vivo, Lyz2 mRNA expression was higher (Fig. 6C), and the macrophages isolated from the IL-4Rαflox/ΔLysMCre mice expressed lower levels of schistosome egg-induced Mrc1, Chi3l3, Retnla, and Arg1 mRNA than littermate controls (Fig. 6D). Together, these data demonstrate that a substantial population of Arg1-expressing AAMs was preserved in egg-challenged IL-4Rαflox/ΔLysMCre mice, likely explaining why Arg1flox/floxTie2Cre and IL-4Rαflox/ΔLysMCre mice display distinct fibrosis phenotypes following acute and chronic infection with S. mansoni [7], [8].
Myeloid cell populations in livers of S. mansoni-infected IL-4Rαflox/ΔLysMCre mice express Il4rα and markers of alternative activation
Lastly, we sorted myeloid cells from the livers of infected IL-4Rαflox/ΔLysMCre mice and IL-4Rαflox/Δ littermate controls to confirm that there are macrophages resistant to Il4rα excision during active infection in the liver and to discern whether Lyz2 expression was responsible for this. As expected [27], myeloid cells isolated from the infected liver were more heterogeneous than peritoneal macrophages, hence we sorted them as CD45+ SiglecF- CD11b+ Ly6G- F4/80+ CD64+ and then separated them based on Ly6C expression with the aim of gaining insight to their identity as recruited or resident cells (Fig. S5). Corroborating observations with peritoneal macrophages exposed to S. mansoni eggs, we found that macrophages isolated from infected IL-4Rαflox/ΔLysMCre livers excise Il4rα less efficiently than the 83–98% deletion efficiency ascribed to mature macrophages when IL-4Rαflox/ΔLysMCre mice were originally characterized [28] (Fig. 7). While Il4rα is expressed by all sorted macrophage populations from IL-4Rαflox/ΔLysMCre livers to at least 50% of levels in littermate controls, the Ly6C- cells in particular manifest almost no deficit. Each sorted population also largely maintains alternative activation marker expression. Arg1 is upregulated several hundred-fold by each sorted population from the infected liver compared to naïve controls although its expression is significantly less in Ly6Cint cells from cre-positive mice. Compared to naïve controls, Relma expression is greatly upregulated in all sorted populations and at comparable levels in both the groups. Similar results were obtained for Chi3l3 and Mrc1 (Fig. S6). Furthermore, we observed that the higher the Lyz2 expression in the sorted macrophage populations, the greater the magnitude of excision of Il4rα.
Discussion
The LysMCre knock-in mouse has a Cre recombinase gene under control of endogenous lysozyme 2 (Lyz2) promoter/enhancer elements and has been used extensively in Cre-lox studies of the myeloid lineage (monocytes, mature macrophages, and granulocytes) for over a decade [28]. In a notable earlier study, conditional IL-4Rα-deficient (IL-4Rαflox/flox) mice were crossed to IL-4RαΔ/ΔLysMCre mice to generate animals with a selective IL-4Rα deletion in macrophages and neutrophils, with the goal of preventing the alternative activation of macrophages [7]. Herbert and colleagues found IL-4Rαflox/ΔLysMCre mice were highly susceptible to acute S. mansoni infection (100% mortality by 8 weeks post-infection) because they developed sepsis and severe hepatic and intestinal histopathology. This acute mortality was also associated with increased IFN-γ production and NOS-2 activity, suggesting that AAMs are critically involved in the suppression of highly pathogenic type-1 immune responses during infection with S. mansoni [29]. We initiated our studies to directly compare the role of IL-4Rα-deficient and Arg1-deficient macrophages in the pathogenesis of fibrosis [8], but we began to question the merits of this strategy when we discovered IL-4Rαflox/ΔLysMCre mice were not displaying the striking susceptibility to S. mansoni infection originally reported by Herbert and colleagues. At a lower dose of 35 cercariae, no difference in mortality occurred between IL-4Rαflox/ΔLysMCre mice and Cre-negative littermates through week 16, and while a larger dose of infectious cercariae accelerated death in both groups, again no difference emerged. It remains difficult to fully explain the difference between the two studies, however the additional controls included in ours, suggest that the global rather than cell-specific deletion of IL-4Rα is the major determinant regulating acute mortality during S. mansoni infection. These unexpected results led us to reexamine the role of IL-4Rα-expressing AAMs in the pathogenesis of schistosomiasis.
We first attempted to verify that the mice were indeed deficient in AAMs by isolating peritoneal macrophages from naïve IL-4Rαflox/ΔLysMCre mice and their Cre-negative littermates and stimulating ex vivo with IL-4. As expected, STAT6 phosphorylation was entirely defective in IL-4-stimulated macrophages but not in lymphocytes isolated from the IL-4Rαflox/ΔLysMCre mice, confirming myeloid cell-specific deletion of IL-4Rα. However, the livers of infected IL-4Rαflox/ΔLysMCre mice showed little to no reduction in the expression of genes associated with alternative activation [3], suggesting that alternative activation was not significantly impaired in vivo during infection.
Most notably, Arg1 mRNA was not reduced, yet Arg1 expression in macrophages is predominantly driven by an IL-4Rα/STAT6-dependent mechanism in schistosomiasis [30]. Arg1 activity was of particular interest because prior studies showed that Arg1-expressing macrophages play a critical host protective role in schistosomiasis by suppressing the pro-inflammatory activity of IL-12/IL-23 during the acute phase and by slowing the progression of IL-13-driven fibrosis in the chronic phase of schistosomiasis [8], [31]. Therefore, we hypothesized that the maintenance of a substantial population of Arg1-expressing AAMs during infection keeps fibrosis and disease progression from being significantly altered in IL-4Rαflox/ΔLysMCre mice, even when chronically infected with S. mansoni.
In the original description of S. mansoni-infected IL-4Rαflox/ΔLysMCre mice, Herbert and colleagues showed that F4/80+ macrophages isolated from the mesenteric lymph nodes of infected mice did not express IL-4Rα, and that peritoneal macrophages from uninfected mice did not respond to IL-4 and IL-13 [7]. Consequently, Arg1 activity was markedly decreased in those macrophages when cultured and stimulated in vitro. The behavior of inflammatory macrophages, which dominate most chronic inflammatory diseases remained unknown, however. To begin dissecting the behavior of inflammatory monocytes, we used thioglycollate, a stimulus recently shown to elicit bone marrow-derived inflammatory monocytes but results in nearly undetectable proliferation of tissue resident cells [27]. We compared thioglycollate-elicited peritoneal macrophages with resident peritoneal macrophages. Under this sterile inflammatory condition, over a quarter of the peritoneal macrophage population in IL-4Rαflox/ΔLysMCre mice resisted LysMCre-mediated gene deletion, expressed IL-4Rα, and subsequently developed an Arg1+ alternatively activated phenotype when stimulated ex vivo with IL-4 or IL-13.
Importantly, when we conducted similar studies eliciting type-2 inflammation by injecting S. mansoni eggs, an even greater fraction of the F4/80hiCD11bhi macrophage population resisted LysMCre-mediated excision of Il4rα. Indeed, if we rechallenged mice with eggs, nearly 100% of the peritoneal macrophages expressed Il4rα. As shown recently by Jenkins et al., the inflammatory cells could result from proliferation as well as recruitment from monocyte precursors [24], [25]. Mechanistically, we found the peritoneal macrophages in this inflammatory environment also expressed very low levels of Lyz2, likely explaining the resistance to LysMCre-mediated excision of Il4rα. In addition to driving proliferation of IL-4Rα+ cells, the high levels of IL-4 present following egg exposure can also suppress Lyz2, maintaining IL-4Rα expression in LysMCre+ cells [27]. Following rechallenge, the peritoneal macrophages also exhibited an alternatively activated phenotype, with IL-4Rαflox/ΔLysMCre mice and Cre-negative littermates expressing comparably high levels of Arg1. However, when the egg-elicited macrophages were given two weeks to mature in vivo, a much larger percentage of the isolated macrophages expressed Lyz2 and deleted Il4rα. Nevertheless, even 18 days after S. mansoni egg challenge, nearly 40% of the peritoneal macrophages in IL-4Rαflox/ΔLysMCre mice retained IL-4Rαcould respond to IL-4, and exhibited a functional AAM phenotype. Macrophages isolated from the livers of infected IL-4Rαflox/ΔLysMCre mice displayed a similar failure to fully delete the IL-4Rαwhen Lyz2 expression is lowest, and their AAM phenotype was also preserved. Sorting on Ly6C expression allowed us to distinguish liver macrophage populations with varying levels of Lyz2 expression, but we were surprised to find the Ly6C- macrophage subset to express the lowest Lyz2 and be most resistant to Il4rα excision. Although Ly6C may be a satisfactory marker for circulating/recently recruited inflammatory monocytes, its regulation during chronic inflammation likely results in more variable expression in the tissue.
Together, our observations of the peritoneum and the infected liver demonstrate that while LysMCre mice are useful for studying gene function in mature tissue macrophages that have expressed Lyz2, they are less effective in chronic disease settings where the resident tissue population is eclipsed by the constant accumulation of immature Lyz2lo macrophages, which in the case of S. mansoni-infected IL-4Rαflox/ΔLysMCre mice, remain IL-4Rα+ and quickly develop into functional AAMs in response to IL-4 and IL-13 found in the local milieu.
IL-4Rαflox/ΔLysMCre mice did develop larger granulomas than IL-4Rαflox/Δ littermates at both acute and chronic time points, suggesting the mature Lyz2hi population is the critical subset of AAMs mediating the downmodulation of granulomatous inflammation at the chronic stage of infection. However, these mice did not manifest increased liver fibrosis, portal hypertension, bleeding, or mortality than the littermate controls. Together, these findings were surprising since the progression of fibrosis in schistosomiasis has been linked with the severity of the egg-induced granulomatous response and the ability to downregulate granuloma formation in the chronic phase of the disease [10], [32], [33]. Nevertheless, in studies of S. mansoni-infected Arg1flox/floxTie2Cre mice, where Arg1 is deleted from all macrophage populations, fibrosis was substantially increased, suggesting that Arg1 activity in macrophages is critical to the regulation of fibrosis. Thus, we conclude that the preservation of Arg1 activity in more imfmature Lyz2lo F4/80hi CD11bhi macrophages from egg-exposed or infected IL-4Rαflox/ΔLysMCre mice explains why IL-4Rαflox/ΔLysMCre mice, in contrast to Arg1flox/floxTie2Cre mice, did not develop a significantly augmented fibrotic response at any time point [8], [31] (Summary diagram, Fig. 8). This also likely explains the greater increase in granulomatous inflammation and fibrosis observed in acutely infected Arg1flox/floxTie2Cre versus Arg1flox/ΔLysMCre reported previously [8].
Our study demonstrates that a substantial subset of macrophages induced in response to a sterile stimulus or pathogen exposure resists LysMCre-mediated genomic excision. We believe this finding is important because numerous studies have employed the LysMCre mouse to dissect gene function in macrophages. In some diseases, including gastrointestinal nematode infection and allergic airway disease [7], [34], [35] the reported results could be due to a failure to delete the gene of interest in a sufficient proportion of more immature macrophages arising from proliferation or recruitment from monocyte precursors. We found that while mature “resident” tissue macrophages successfully delete the gene of interest, newly differentiating macrophages in inflammatory environments transcribe insufficient Lyz2 to efficiently accomplish the Cre-mediated deletion. Our discovery suggests a new experimental approach to distinguish the function of resident tissue and fully mature macrophages from more immature Lyz2-negative cells, an emerging topic for research in many infections and inflammatory diseases. Accordingly, our findings complement a recent study showing tissue macrophages and AAMs derived from monocytes are phenotypically distinct [27].
Our findings also demonstrate how quickly this immature Lyz2lo macrophage population can become alternatively activated with high expression of Arg1, which we have shown critically controls the pathogenesis of fibrosis in schistosomiasis [8]. This conclusion is consistent with another recent study that found inflammatory monocytes recruited to the skin quickly adopt a suppressive AAM-like phenotype in response to IL-4 [36]. Collectively, we conclude that it is a Lyz2lo IL-4Rα+ Arg1+ population of F4/80hiCD11bhi macrophages that is critically involved in the suppression of fibrosis in chronic schistosomiasis, while the Lyz2hi IL-4Rα+ population of mature resident macrophages controls the magnitude of the egg-induced inflammatory response at both acute and chronic time points post-infection.
Materials and Methods
Ethics statement
The National Institute of Allergy and Infectious Diseases Division of Intramural Research Animal Care and Use Program, as part of the National Institutes of Health Intramural Research Program, approved all of the experimental procedures (protocol LPD 16E). The Program complies with all applicable provisions of the Animal Welfare Act (http://www.aphis.usda.gov/animal_welfare/downloads/awa/awa.pdf) and other federal statutes and regulations relating to animals.
Animals
IL-4Rαflox/Δ LysMWT/Cre mice backcrossed on a BALB/c background were kindly provided by Dr. Fred Finkelman (U. Cincinnati, Ohio) and Dr. Frank Brombacher (University of Cape Town; Cape Town, South Africa) [7]. IL-4Rαflox/flox females were crossed with IL-4RαΔ/Δ LysMWT/Cre males to generate IL-4Rαflox/Δ LysMWT/Cre mice (called IL-4Rαflox/ΔLysMCre in this paper) and Cre-negative IL-4Rαflox/Δ littermates. All cells in both the Cre-positive and Cre-negative mice maintain the Il4rα gene on one allele. This breeding scheme prevents embryonic deletion of IL-4Rα by Cre-expressing females. BALB/c and IL-4RαΔ/Δ mice were obtained from Taconic Farms Inc (Derwood, MD). All animals were housed under specific pathogen-free conditions at the National Institutes of Health in an American Association for the Accreditation of Laboratory Animal Care-approved facility.
Parasite infection
Mice were infected percutaneously via the tail with 35 or 100 cercariae, as indicated, with a Puerto Rican strain of Schistosoma mansoni (NMRI) obtained from infected Biomphalaria glabrata snails (Biomedical Research Institute; Rockville, MD). Mice were perfused at the time of euthanasia to determine worm and tissue egg burdens as described previously [37].
Hematology
Serum was analyzed for liver enzyme quantification at the National Institutes of Health Clinical Center using a Vista Analyzer (Siemens; Deerfield, IL). IL-13Rα2 serum levels were determined by ELISA as previously described [38].
Histopathology
Liver tissue was fixed in Bouin-Hollande solution, embedded in paraffin for sectioning, and stained (Histopath of America; Clinton, MD) with Wright's Giemsa for analysis of inflammation or picrosirius red for fibrosis analysis. A blinded pathologist measured the size of approximately 30 granulomas in Giemsa-stained sections of each sample. Swiss rolls of small intestine were fixed as above and stained with hematoxylin and eosin for blinded scoring of inflammation.
Fibrosis assay
Hydroxyproline was measured as a surrogate for collagen content. A known weight of liver tissue was hydrolyzed in 6 N HCl at 110°C for 18 h and then neutralized in 10 N NaOH before colorization. A standard curve comprised of dilutions of 1 mM hydroxyproline (Sigma-Aldrich; St. Louis, MO) was used for quantification [39].
Hepatic leukocyte isolation for intracellular cytokine staining
About 200 mg of granulomatous liver was ground into a single-cell suspension through a 100-µm nylon mesh. Leukocytes were separated on a 40% Percoll (Sigma-Aldrich) gradient (2000 rpm for 15 min) and treated for 2 min with 1 ml ACK (ammonium chloride–potassium bicarbonate) lysis buffer to lyse erythrocytes. After 3 hours of stimulation with phorbol 12-myristate 13-acetate (PMA 10 ng/ml), ionomycin (1 µg/ml), and Brefeldin A (BFA, 10 µg/ml), leukocytes were fixed and permeabilized for 30 minutes (Cytofix/Cytoperm buffer; BD Biosciences; San Diego, CA) and then stained for 30 minutes with antibodies for CD4 (eBioscience; San Diego, CA), IFN-γ (eBioscience), IL-4 (eBioscience), and IL-13 (eBioscience) diluted in the Permwash buffer (BD Biosciences). Expression of CD4 and the intracellular cytokines was analyzed with a BD FACSCanto II flow cytometer and FlowJo v.7.6 software (Tree Star; Ashland, OR).
Hepatic leukocyte isolation for sorting of myeloid cells
Whole naïve or granulomatous livers were chopped into fine pieces with a razor blade and digested in 100 units/ml collagenase (Sigma) for 1 hr at 37oC with rocking. The tissue was then ground into a single-cell suspension through a 100-µm nylon mesh. Hepatocytes were pelleted out with a 50 g spin for 5 min for cleaner density separation. Leukocytes were separated on a 40% Percoll (Sigma-Aldrich) gradient (2000 rpm for 15 min) and treated for 2 min with 1 ml ACK (ammonium chloride–potassium bicarbonate) lysis buffer to lyse erythrocytes. Leukocytes were stained for 30 minutes with antibodies for CD16/32 (BDBiosciences), CD45 (Biolegend; San Diego, CA), CD11b (Biolegend), Siglec F (BDBiosciences), Ly6G (BDBiosciences), F4/80 (Biolegend), CD64 (Biolegend), and Ly6C (Biolegend) diluted in FACS buffer. CD45+ SiglecF- CD11b+ Ly6G- F4/80+ CD64+ cells were sorted with at least 90% purity from amongst the stained cells using a FACS Aria (BDBiosciences).
RNA isolation and quantitative real-time PCR
Liver tissue was homogenized in TRIzol Reagent (Life Technologies; Grand Island, NY) using Precellys 24 (Bertin Technologies; Montigny-le-Bretonneux, France). Total RNA was extracted from the homogenate by addition of chloroform followed by the recommendations of the MagMax-96 Total RNA Isolation Kit (Life Technologies). Total RNA was isolated from peritoneal cells with an RNeasy kit (Qiagen). RNA from all cell types was then reverse transcribed using SuperScript II Reverse Transcriptase (Life Technologies). Real-time RT-PCR was performed on an ABI Prism 7900HT Sequence Detection System (Applied Biosystems). Quantities of mRNA expressed by a particular gene were determined using Power SYBR Green PCR Master Mix (Applied Biosystems), normalized to ribosomal protein, large, P2 (RPLP2) mRNA levels in each sample, and then articulated as a relative increase or decrease compared with mRNA levels expressed by the same gene in uninfected controls. Primers were designed using Primer Express software (version 2.0; Applied Biosystems). Forward and reverse primer sequences are listed in Table S1.
Peritoneal macrophage isolation
Peritoneal cells were collected by washing the peritoneal cavity with PBS containing 5 mM EDTA. The cells were stained for 30 minutes with anti-mouse antibodies for F4/80 (Biolegend), CD11b (Biolegend), and CD16/32 (BD) diluted in the same buffer. F4/80hiCD11bhi cells were sorted with at least 90% purity from amongst the stained cells using a FACS Aria (BDBiosciences).
Ex vivo STAT6 phosphorylation
Mice were intraperitoneally (i.p.) injected with 2 ml 3% thioglycollate (BD; Franklin Lakes, NJ) to elicit peritoneal macrophage recruitment or left untreated, as indicated. 4 days later, peritoneal cells from both groups were harvested as described above, and equal numbers of cells per mouse were resuspended with 20 ng/ml recombinant murine IL-4 (Peprotech) in complete RMPI or complete RMPI alone. The resuspended cells were placed in a 37°C water bath for 30 minutes with periodic agitation. Next, cells were fixed with 1.5% paraformaldehyde, washed, and permeabilized with cold methanol overnight at −20°C. Permeabilized cells were washed twice with PBS containing 0.1% bovine serum albumin and stained with anti-mouse STAT6 (BD), F4/80 (Biolegend), CD11b (eBioscience), Gr1 (BD Pharmingen), and CD16/32 (BD) for 1 hour on a shaker at room temperature. Phosphorylation of STAT6 in F4/80hiCD11bhiGr1– macrophages and F4/80l°CD11bloGr1– lymphocytes was measured using a BD FACSCanto II flow cytometer and FlowJo v.7.6 software (Tree Star; Ashland, OR).
DNA isolation and PCR
To extract DNA, equal numbers of FACS sorted peritoneal cells were resuspended in 25 mM NaOH, incubated at 95°C for 15 minutes, and neutralized with 40 mM Tris-HCl. DNA was amplified with GoTaq DNA Polymerase (Promega) with the following primers: Il4rα wild-type: F - 5′-GTACAGCGCACATTGTTTTT-3′, R - 5′-CTCGGCGCACTGACCCATCT-3′; Il4rα knockout: F - 5′-GGCTGCCCTGGAATAACC-3′, R - 5′-CCTTTGAGAACTGCGGGCT-3′. Gel was imaged and band intensity quantified with BioSpectrum set up with VisionWorksLS software (UVP; Upland, CA).
Parasite egg treatment and subsequent macrophage analyses
5000 live Schistosoma mansoni eggs (obtained from the same source as the cercariae described above) were injected i.p. to prime some mice on day 0 while others were left untreated. On day 14, some of the primed mice were challenged i.p. with 5000 live eggs, and some of the primed mice were left unchallenged. On day 18, peritoneal cells were harvested from each group of mice (naïve, primed/rested, primed/rechallenged). Equal numbers of unsorted peritoneal cells were stained with anti-mouse antibodies against F4/80 (Biolegend), CD11b (eBioscience), CD16/32 (BD), and CD206 (mouse mannose receptor, C type 1) (Biolegend) or with a rat IgG2a isotype control. CD206 fluorescence on F4/80hiCD11bhi macrophages was measured using a BD FACSCanto II flow cytometer and FlowJo v.7.6 software (Tree Star; Ashland, OR). F4/80hiCD11bhi peritoneal cells were also sorted as described above. Some sorted cells were spun for 5 mins with a Shandon Cytospin 3 centrifuge (Thermo Scientific; Waltham, MA) onto a slide before being fixed with methanol and stained with Diff-Quik (Boehringer). Aliquots of 5×105 sorted cells were resuspended in lysis buffer and arginase activity was measured as previously described [39].
Statistical analysis
All data were analyzed with Prism (Version 5; GraphPad). Data sets were compared with a two-tailed t-test, and differences were considered significant if P values were less than 0.05.
Accession numbers
Rplp2: NM_026020, Il4: NM_021283, Il13: NM_008355, Il13rα2: NM_008356, Il10: NM_010548, Chi3l3: NM_009892, Retnla: NM_020509, Mrc1: NM_008625, Arg1: NM_007482, Col6α: NM_009933, Timp1: NM_001044384, Mmp12: NM_008605, Il4rα: NM_001008700, Lyz2: NM_017372, Ifnγ: NM_008337, Il12p40: NM_008352
Supporting Information
Zdroje
1. MosserDM, EdwardsJP (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8: 958–969.
2. MurrayPJ, AllenJE, BiswasSK, FisherEA, GilroyDW, et al. (2014) Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines. Immunity 41: 14–20.
3. GordonS (2003) Alternative activation of macrophages. Nat Rev Immunol 3: 23–35.
4. WynnTA (2004) Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat Rev Immunol 4: 583–594.
5. DuffieldJS, LupherM, ThannickalVJ, WynnTA (2013) Host responses in tissue repair and fibrosis. Annu Rev Pathol 8: 241–276.
6. AllenJE, WynnTA (2011) Evolution of Th2 immunity: a rapid repair response to tissue destructive pathogens. PLoS Pathog 7: e1002003.
7. HerbertDR, HolscherC, MohrsM, ArendseB, SchwegmannA, et al. (2004) Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology. Immunity 20: 623–635.
8. PesceJT, RamalingamTR, Mentink-KaneMM, WilsonMS, El KasmiKC, et al. (2009) Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis. PLoS Pathog 5: e1000371.
9. WynnTA, BarronL (2010) Macrophages: master regulators of inflammation and fibrosis. Semin Liver Dis 30: 245–257.
10. Mentink-KaneMM, CheeverAW, WilsonMS, MadalaSK, BeersLM, et al. (2011) Accelerated and progressive and lethal liver fibrosis in mice that lack interleukin (IL)-10, IL-12p40, and IL-13Ralpha2. Gastroenterology 141: 2200–2209.
11. WilsonMS, ElnekaveE, Mentink-KaneMM, HodgesMG, PesceJT, et al. (2007) IL-13Ralpha2 and IL-10 coordinately suppress airway inflammation, airway-hyperreactivity, and fibrosis in mice. J Clin Invest 117: 2941–2951.
12. BarronL, WynnTA (2011) Macrophage activation governs schistosomiasis-induced inflammation and fibrosis. Eur J Immunol 41: 2509–2514.
13. WynnTA, ThompsonRW, CheeverAW, Mentink-KaneMM (2004) Immunopathogenesis of schistosomiasis. Immunol Rev 201: 156–167.
14. MunderM, EichmannK, ModolellM (1998) Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype. J Immunol 160: 5347–5354.
15. PauleauAL, RutschmanR, LangR, PernisA, WatowichSS, et al. (2004) Enhancer-mediated control of macrophage-specific arginase I expression. J Immunol 172: 7565–7573.
16. Mentink-KaneMM, CheeverAW, ThompsonRW, HariDM, KabatereineNB, et al. (2004) IL-13 receptor alpha 2 down-modulates granulomatous inflammation and prolongs host survival in schistosomiasis. Proc Natl Acad Sci U S A 101: 586–590.
17. ChiaramonteMG, DonaldsonDD, CheeverAW, WynnTA (1999) An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response. J Clin Invest 104: 777–785.
18. WynnTA, CheeverAW, JankovicD, PoindexterRW, CasparP, et al. (1995) An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection. Nature 376: 594–596.
19. HoffmannKF, CheeverAW, WynnTA (2000) IL-10 and the dangers of immune polarization: excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis. J Immunol 164: 6406–6416.
20. ChiaramonteMG, CheeverAW, MalleyJD, DonaldsonDD, WynnTA (2001) Studies of murine schistosomiasis reveal interleukin-13 blockade as a treatment for established and progressive liver fibrosis. Hepatology 34: 273–282.
21. FallonPG, RichardsonEJ, McKenzieGJ, McKenzieAN (2000) Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent. J Immunol 164: 2585–2591.
22. MartinezFO, HelmingL, GordonS (2009) Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 27: 451–483.
23. DewalsBG, MarillierRG, HovingJC, LeetoM, SchwegmannA, et al. (2010) IL-4Ralpha-independent expression of mannose receptor and Ym1 by macrophages depends on their IL-10 responsiveness. PLoS Negl Trop Dis 4: e689.
24. JenkinsSJ, RuckerlD, ThomasGD, HewitsonJP, DuncanS, et al. (2013) IL-4 directly signals tissue-resident macrophages to proliferate beyond homeostatic levels controlled by CSF-1. J Exp Med 210: 2477–2491.
25. JenkinsSJ, RuckerlD, CookPC, JonesLH, FinkelmanFD, et al. (2011) Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation. Science 332: 1284–1288.
26. WynnTA, ChawlaA, PollardJW (2013) Macrophage biology in development, homeostasis and disease. Nature 496: 445–455.
27. GundraUM, GirgisNM, RuckerlD, JenkinsS, WardLN, et al. (2014) Alternatively activated macrophages derived from monocytes and tissue macrophages are phenotypically and functionally distinct. Blood 123: e110–122.
28. ClausenBE, BurkhardtC, ReithW, RenkawitzR, ForsterI (1999) Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res 8: 265–277.
29. HoffmannKF, JamesSL, CheeverAW, WynnTA (1999) Studies with double cytokine-deficient mice reveal that highly polarized Th1- and Th2-type cytokine and antibody responses contribute equally to vaccine-induced immunity to Schistosoma mansoni. J Immunol 163: 927–938.
30. HesseM, ModolellM, La FlammeAC, SchitoM, FuentesJM, et al. (2001) Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism. J Immunol 167: 6533–6544.
31. HerbertDR, OrekovT, RolosonA, IliesM, PerkinsC, et al. (2010) Arginase I suppresses IL-12/IL-23p40-driven intestinal inflammation during acute schistosomiasis. J Immunol 184: 6438–6446.
32. WynnTA, CheeverAW, WilliamsME, HienyS, CasparP, et al. (1998) IL-10 regulates liver pathology in acute murine Schistosomiasis mansoni but is not required for immune down-modulation of chronic disease. J Immunol 160: 4473–4480.
33. ChiaramonteMG, Mentink-KaneM, JacobsonBA, CheeverAW, WhittersMJ, et al. (2003) Regulation and function of the interleukin 13 receptor alpha 2 during a T helper cell type 2-dominant immune response. J Exp Med 197: 687–701.
34. NieuwenhuizenNE, KirsteinF, JayakumarJ, EmediB, HurdayalR, et al. (2012) Allergic airway disease is unaffected by the absence of IL-4Ralpha-dependent alternatively activated macrophages. J Allergy Clin Immunol 130: 743–750 e748.
35. HerediaJE, MukundanL, ChenFM, MuellerAA, DeoRC, et al. (2013) Type 2 innate signals stimulate fibro/adipogenic progenitors to facilitate muscle regeneration. Cell 153: 376–388.
36. EgawaM, MukaiK, YoshikawaS, IkiM, MukaidaN, et al. (2013) Inflammatory monocytes recruited to allergic skin acquire an anti-inflammatory M2 phenotype via basophil-derived interleukin-4. Immunity 38: 570–580.
37. CheeverAW, WilliamsME, WynnTA, FinkelmanFD, SederRA, et al. (1994) Anti-IL-4 treatment of Schistosoma mansoni-infected mice inhibits development of T cells and non-B, non-T cells expressing Th2 cytokines while decreasing egg-induced hepatic fibrosis. J Immunol 153: 753–759.
38. KhodounM, LewisCC, YangJQ, OrekovT, PotterC, et al. (2007) Differences in expression, affinity, and function of soluble (s)IL-4Ralpha and sIL-13Ralpha2 suggest opposite effects on allergic responses. J Immunol 179: 6429–6438.
39. Wynn TA, Barron L, Thompson RW, Madala SK, Wilson MS, et al. (2011) Quantitative assessment of macrophage functions in repair and fibrosis. Curr Protoc Immunol Chapter 14: Unit14 22.
Štítky
Hygiena a epidemiologie Infekční lékařství LaboratořČlánek vyšel v časopise
PLOS Pathogens
2014 Číslo 9
- Perorální antivirotika jako vysoce efektivní nástroj prevence hospitalizací kvůli COVID-19 − otázky a odpovědi pro praxi
- Stillova choroba: vzácné a závažné systémové onemocnění
- Diagnostický algoritmus při podezření na syndrom periodické horečky
- Jak souvisí postcovidový syndrom s poškozením mozku?
- Diagnostika virových hepatitid v kostce – zorientujte se (nejen) v sérologii
Nejčtenější v tomto čísle
- The Secreted Peptide PIP1 Amplifies Immunity through Receptor-Like Kinase 7
- The Ins and Outs of Rust Haustoria
- Kaposi's Sarcoma Herpesvirus MicroRNAs Induce Metabolic Transformation of Infected Cells
- RNF26 Temporally Regulates Virus-Triggered Type I Interferon Induction by Two Distinct Mechanisms